AZ said in a statement on the deal this morning that IVX-A12 is furthest along in development among vaccines targeting RSV and hMPV and also offers a “differentiated profile” compared to GSK ...

European Semester 2025: Council adopts country-specific recommendations and approves conclusions on the 2025 in-depth reviews Ministers adopted its country-specific recommendations (CSRs) on the ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...